Antithrombins: Their Potential as Antithrombotic Agents Journal Articles

abstract

• The inhibition of thrombin is the key to the prevention and treatment of thrombotic disorders. Although heparin is an extremely effective anticoagulant, it has certain limitations that are not shared by newer thrombin inhibitors. As a result, these novel inhibitors may have advantages over heparin in certain clinical settings.

authors

• Weitz, Jeffrey
• Hirsh, Jack

status

• published 

publication date

• February 1992

has subject area

• 1103 Clinical Sciences (FoR)
• Antithrombins (MeSH)
• General & Internal Medicine (Science Metrix)
• Hemostasis (MeSH)
• Heparin (MeSH)
• Heparin, Low-Molecular-Weight (MeSH)
• Heparinoids (MeSH)
• Humans (MeSH)
• Thrombosis (MeSH)

published in

• Annual Review of Medicine  Journal

keywords

• Antithrombins
• Hemostasis
• Heparin
• Heparin, Low-Molecular-Weight
• Heparinoids
• Humans
• Thrombosis

Digital Object Identifier (DOI)

• 10.1146/annurev.me.43.020192.000301

PubMed ID

• 1374601

start page

• 9

end page

• 16

volume

• 43

issue

• 1